Phase II Study of Irinotecan in Combination with Capecitabine on a 3-Weekly Schedule as First-Line Chemotherapy for Patients with Metastatic or Locally Advanced Colorectal Cancer. (2013). Journal of Analytical Oncology, 2(3),  151-159. https://doi.org/10.6000/1927-7229.2013.02.03.4